UB17:LSE:LSE-UBS MSCI EMU Value UCITS EUR Adis (GBX)

ETF | Others |

Last Closing

USD 4037.5

Change

+6.00 (+0.15)%

Market Cap

N/A

Volume

1.05K

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-02-20 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
0R1O:LSE Amazon.com Inc.

-3.00 (-1.35%)

USD 1,607.29B
0R1I:LSE NVIDIA Corp.

+1.31 (+0.95%)

USD 618.20B
LCJD:LSE Amundi MSCI Japan (DR) UCITS E..

-0.03 (-0.16%)

USD 588.35B
LCJP:LSE Lyxor Core MSCI Japan (DR) UCI..

-0.02 (-0.14%)

USD 588.35B
0R1G:LSE Home Depot Inc.

N/A

USD 373.16B
0QZK:LSE Coca-Cola Co.

+1.70 (+2.44%)

USD 266.08B
0QZO:LSE 0QZO

+1.30 (+1.18%)

USD 258.54B
PRJU:LSE Amundi Index Solutions - Amund..

-0.03 (-0.10%)

USD 244.75B
0QZ3:LSE Qualcomm Inc.

-4.78 (-2.74%)

USD 202.26B
0R24:LSE Intel Corp.

+0.45 (+1.81%)

USD 196.14B

ETFs Containing UB17:LSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 9.87% 87% B+ 81% B-
Dividend Return 0.01% 22% F 20% F
Total Return 9.88% 87% B+ 81% B-
Trailing 12 Months  
Capital Gain 12.05% 57% F 61% D-
Dividend Return 0.05% 29% F 26% F
Total Return 12.10% 56% F 59% D-
Trailing 5 Years  
Capital Gain 28.84% 52% F 63% D
Dividend Return 0.19% 33% F 45% F
Total Return 29.02% 49% F 61% D-
Average Annual (5 Year Horizon)  
Capital Gain 8.43% 56% F 61% D-
Dividend Return 8.43% 55% F 61% D-
Total Return 0.00% 18% F 12% F
Risk Return Profile  
Volatility (Standard Deviation) 12.21% 59% D- 75% C
Risk Adjusted Return 69.05% 68% D+ 80% B-
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (GBX)

Quarterly Financials (GBX)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.